Notices. Notice
194 words·~1 min read·
/register/2004/01/09/04-437·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 3710-08-M DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Use of Purified Invaplex From Gram Negative Bacteria as a Vaccine AGENCY: Department of the Army, DoD. ACTION: Notice. SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent No. 6,277,379 entitled “Use of Purified Invaplex from Gram Negative Bacteria as a Vaccine,” filed August 21, 2001.
Foreign rights are also available (PCT/US99/22772). The United States Government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney,
(301)619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment,
(301)619-6664, both at telefax
(301)619-5034. SUPPLEMENTARY INFORMATION: A novel composition comprising Invaplex from gram-negative bacteria is described and is effective as a vaccine against gram-negative bacterial infection. Luz D. Ortiz, Army Federal Register Liaison Officer. [FR Doc. 04-437 Filed 1-8-04; 8:45 am]
Connectionstraces to 1
Traces to 1 document